AFFYMETRIX INC
10-Q, EX-27, 2000-08-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: AFFYMETRIX INC, 10-Q, 2000-08-14
Next: COMMONWEALTH INCOME & GROWTH FUND I, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM ITEM 1
OF THE COMPANY'S FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2000 AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          85,247
<SECURITIES>                                   334,325
<RECEIVABLES>                                   38,028
<ALLOWANCES>                                   (1,461)
<INVENTORY>                                     17,011
<CURRENT-ASSETS>                               476,396
<PP&E>                                          70,652
<DEPRECIATION>                                (21,646)
<TOTAL-ASSETS>                                 588,986
<CURRENT-LIABILITIES>                           46,195
<BONDS>                                        375,000
                                0
                                          0
<COMMON>                                           276
<OTHER-SE>                                     159,515
<TOTAL-LIABILITY-AND-EQUITY>                   588,986
<SALES>                                         76,855
<TOTAL-REVENUES>                                85,642
<CGS>                                           30,717
<TOTAL-COSTS>                                   30,717
<OTHER-EXPENSES>                                70,356
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               8,606
<INCOME-PRETAX>                               (12,361)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (12,361)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (12,361)
<EPS-BASIC>                                     (0.46)
<EPS-DILUTED>                                   (0.46)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission